[144] Vicarious Surgical Inc. SEC Filing

Rhea-AI Filing Summary

Vicarious Surgical Inc. (RBOT) Form 144 shows a proposed sale of 239 shares of Class A common stock through UBS Financial Services with an aggregate market value of $1,386 and an approximate sale date of 09/03/2025 on the NYSE. The filing reports the securities were acquired on 09/02/2025 via a restricted stock lapse from Vicarious Surgical Inc. and indicates 696 shares were acquired in that transaction.

The filing also discloses three prior sales by the listed seller, Sammy Khalifa, during the past three months: 239 shares on 06/03/2025 for $1,641, 223 shares on 06/23/2025 for $1,650, and 653 shares on 08/20/2025 for $3,801. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

• Contains specific proposed sale details: 239 Class A shares with aggregate market value $1,386
• Discloses acquisition source and date: 696 shares acquired via restricted stock lapse on 09/02/2025
• Lists recent prior sales with dates and gross proceeds for transparency (06/03/2025, 06/23/2025, 08/20/2025)

Negative

• Filer identification fields (CIK/CCC and submission contact) appear blank or not provided in the content
• The filing contains no issuer financial results or operational details—only transactional disclosure

Insights

Securities Analyst

TL;DR: Routine Form 144 filing disclosing a small proposed sale and recent prior sales; no new operational or financial disclosure.

The filing documents a proposed sale of 239 Class A shares through UBS with specific acquisition details (restricted stock lapse on 09/02/2025) and lists three prior sales by the named seller with gross proceeds. From a market-disclosure perspective this is a routine insider/affiliate notice required under Rule 144 and contains transactional detail but no operational results, guidance, or new issuer-specific financial metrics. The filing helps maintain transparency about insider selling activity but does not itself convey material corporate developments.

Corporate Governance Expert

TL;DR: Disclosure meets procedural requirements; includes representation regarding undisclosed material information.

The form includes the required representation that the selling person is unaware of undisclosed material adverse information and documents the acquisition source (restricted stock lapse) and broker. Contact and filer identifier fields in the filing appear blank in the provided content, while the seller name and prior sales are listed. This filing appears procedural and consistent with Rule 144 notice obligations rather than signaling governance or control changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	239	1386	5298253	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	09/02/2025	Restricted Stock Lapse	Vicarious Surgical Inc			696	09/02/2025	Restricted Stock Lapse

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Sammy Khalifa 78 4th Ave Waltham MA 02451	Class A Common Stock	06/03/2025	239	1641
Sammy Khalifa 78 4th Ave Waltham MA 02451	Class A Common Stock	06/23/2025	223	1650
Sammy Khalifa 78 4th Ave Waltham MA 02451	Class A Common Stock	08/20/2025	653	3801

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Vicarious Surgical Inc. (RBOT) disclose?

The form discloses a proposed sale of 239 Class A shares via UBS with an aggregate market value of $1,386 and an approximate sale date of 09/03/2025.

How were the shares being sold acquired according to the filing?

The filing states the shares were acquired on 09/02/2025 by restricted stock lapse from Vicarious Surgical Inc., showing 696 shares acquired in that transaction.

Does the filing show prior sales by the seller for RBOT?

Yes. The filing lists three sales by Sammy Khalifa: 239 shares on 06/03/2025 for $1,641, 223 shares on 06/23/2025 for $1,650, and 653 shares on 08/20/2025 for $3,801.

Through which broker is the proposed sale to be executed?

The proposed sale is to be executed through UBS Financial Services Inc, listed with an address in Weehawken, NJ.

Does the filing indicate any undisclosed material information about the issuer?

The signer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.